Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Compugen to Participate in Upcoming Investor Conferences PR Newswire - Thu Feb 19, 6:00AM CST

HOLON, Israel , Feb. 19, 2026 /PRNewswire/ -- Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 1.7900 (+5.29%)
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 PR Newswire - Tue Feb 17, 6:00AM CST

HOLON, Israel , Feb. 17, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 1.7900 (+5.29%)
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors PR Newswire - Thu Feb 12, 6:00AM CST

HOLON, Israel , Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 1.7900 (+5.29%)
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million PR Newswire - Wed Dec 17, 2025

HOLON, Israel , Dec. 17, 2025 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7900 (+5.29%)
Compugen: Q3 Earnings Snapshot AP - Mon Nov 10, 2025

Compugen: Q3 Earnings Snapshot

CGEN : 1.7900 (+5.29%)
Compugen Reports Third Quarter 2025 Results PR Newswire - Mon Nov 10, 2025

HOLON, Israel , Nov. 10, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7900 (+5.29%)
Compugen to Participate in Stifel 2025 Healthcare Conference PR Newswire - Tue Nov 4, 2025

HOLON, Israel , Nov. 4, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.7900 (+5.29%)
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 PR Newswire - Mon Oct 27, 2025

HOLON, Israel , Oct. 27, 2025 /PRNewswire/ --  Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.7900 (+5.29%)
Analysts Offer Insights on Healthcare Companies: Compugen (CGEN) and AbbVie (ABBV) Tipranks - Wed Oct 15, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compugen (CGEN – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments.Elevate...

CGEN : 1.7900 (+5.29%)
ABBV : 224.35 (-1.91%)
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 PR Newswire - Mon Oct 13, 2025

HOLON, Israel , Oct. 13, 2025 /PRNewswire/ --  Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7900 (+5.29%)

Barchart Exclusives

3 Steps to a Simple Trading System Barchart - 13 minutes ago
We only need to use three things to develop a simple trading system: Trend, Fundamentals, and Filters. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot